|
|
||||||||
Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262
An in vitro proliferative defect has been observed in HIV-1-specific CD4+ T cells from infected subjects with high-level plasma HIV-1 viremia. To determine the mechanism of this defect, HIV-1 Gag-specific CD4+ T cells from treated and untreated HIV-1-infected subjects were analyzed for cytokine profile, proliferative capacity, and maturation state. Unexpectedly high frequencies of HIV-1-specific, IL-2-producing CD4+ T cells were measured in subjects with low or undetectable plasma HIV-1 loads, regardless of treatment status, and IL-2 frequencies correlated inversely with viral loads. IL-2-producing CD4+ T cells also primarily displayed a central memory (TCm; CCR7+CD45RA-) maturation phenotype, whereas IFN-
-producing cells were mostly effector memory (TEm, CCR7-CD45RA-). Among Gag-specific, IFN-
-producing CD4+ T cells, higher TEm frequencies and lower TCm frequencies were observed in untreated, high viral load subjects than in subjects with low viral loads. The percentage of HIV-1 Gag-specific CD4+ TCm correlated inversely with HIV-1 viral load and directly with Gag-specific CD4+ T cell proliferation, whereas the opposite relationships were observed for HIV-1-specific CD4+ TEm. These results suggest that HIV-1 viremia skews Gag-specific CD4+ T cells away from an IL-2-producing TCm phenotype and toward a poorly proliferating TEm phenotype, which may limit the effectiveness of the HIV-1-specific immune response.
This article has been cited by other articles:
![]() |
N. Zheng, M. Fujiwara, T. Ueno, S. Oka, and M. Takiguchi Strong Ability of Nef-Specific CD4+ Cytotoxic T Cells To Suppress Human Immunodeficiency Virus Type 1 (HIV-1) Replication in HIV-1-Infected CD4+ T Cells and Macrophages J. Virol., August 1, 2009; 83(15): 7668 - 7677. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Foxall, C. S. Cortesao, A. S. Albuquerque, R. S. Soares, R. M. M. Victorino, and A. E. Sousa Gag-Specific CD4+ T-Cell Frequency Is Inversely Correlated with Proviral Load and Directly Correlated with Immune Activation in Infection with Human Immunodeficiency Virus Type 2 (HIV-2) but Not HIV-1 J. Virol., October 1, 2008; 82(19): 9795 - 9799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Tilton, M. M. Manion, M. R. Luskin, A. J. Johnson, A. A. Patamawenu, C. W. Hallahan, N. A. Cogliano-Shutta, J. M. Mican, R. T. Davey Jr., S. Kottilil, et al. Human Immunodeficiency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro J. Virol., April 15, 2008; 82(8): 3997 - 4006. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Palmer, D. G. Mack, A. K. Martin, M. Gillespie, M. M. Mroz, L. A. Maier, and A. P. Fontenot Up-Regulation of Programmed Death-1 Expression on Beryllium-Specific CD4+ T Cells in Chronic Beryllium Disease J. Immunol., February 15, 2008; 180(4): 2704 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, S. R. Permar, A. P. Buzby, and N. L. Letvin Memory CD4+ T-Lymphocyte Loss and Dysfunction during Primary Simian Immunodeficiency Virus Infection J. Virol., August 1, 2007; 81(15): 8009 - 8015. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D'Souza, A. P. Fontenot, D. G. Mack, C. Lozupone, S. Dillon, A. Meditz, C. C. Wilson, E. Connick, and B. E. Palmer Programmed Death 1 Expression on HIV-Specific CD4+ T Cells Is Driven by Viral Replication and Associated with T Cell Dysfunction J. Immunol., August 1, 2007; 179(3): 1979 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bohler, M. von Au, N. Klose, K. Muller, B. Coulibaly, F. Nauwelaers, H. P. Spengler, G. Kynast-Wolf, and H.-G. Krausslich Evaluation of a Simplified Dual-Platform Flow Cytometric Method for Measurement of Lymphocyte Subsets and T-Cell Maturation Phenotypes in the Population of Nouna, Burkina Faso Clin. Vaccine Immunol., June 1, 2007; 14(6): 775 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Tilton, M. R. Luskin, A. J. Johnson, M. Manion, C. W. Hallahan, J. A. Metcalf, M. McLaughlin, R. T. Davey Jr., and M. Connors Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells Are a Consequence of Antigen Load J. Virol., March 15, 2007; 81(6): 2713 - 2725. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Tilton, A. J. Johnson, M. R. Luskin, M. M. Manion, J. Yang, J. W. Adelsberger, R. A. Lempicki, C. W. Hallahan, M. McLaughlin, J. M. Mican, et al. Diminished Production of Monocyte Proinflammatory Cytokines during Human Immunodeficiency Virus Viremia Is Mediated by Type I Interferons J. Virol., December 1, 2006; 80(23): 11486 - 11497. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moris, A. Pajot, F. Blanchet, F. Guivel-Benhassine, M. Salcedo, and O. Schwartz Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer Blood, September 1, 2006; 108(5): 1643 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Cohen, S. Pouvelle-Moratille, X.-F. Wang, S. Farci, G. Munier, D. Charron, A. Menez, M. Busson, and B. Maillere Scanning the HIV Genome for CD4+ T Cell Epitopes Restricted to HLA-DP4, the Most Prevalent HLA Class II Molecule J. Immunol., May 1, 2006; 176(9): 5401 - 5408. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Jansen, I. M. De Cuyper, B. Hooibrink, A. K. van der Bij, D. van Baarle, and F. Miedema Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study Blood, February 15, 2006; 107(4): 1427 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Palmer, N. Blyveis, A. P. Fontenot, and C. C. Wilson Functional and Phenotypic Characterization of CD57+CD4+ T Cells and Their Association with HIV-1-Induced T Cell Dysfunction J. Immunol., December 15, 2005; 175(12): 8415 - 8423. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Seth, D. Kaufmann, T. Lahey, E. S. Rosenberg, and K. W. Wucherpfennig Expansion and Contraction of HIV-Specific CD4 T Cells with Short Bursts of Viremia, but Physical Loss of the Majority of These Cells with Sustained Viral Replication J. Immunol., November 15, 2005; 175(10): 6948 - 6958. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zaunders, M. L. Munier, D. E. Kaufmann, S. Ip, P. Grey, D. Smith, T. Ramacciotti, D. Quan, R. Finlayson, J. Kaldor, et al. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection Blood, September 1, 2005; 106(5): 1660 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, J. E. Schmitz, P. M. Acierno, S. Santra, R. A. Subbramanian, D. H. Barouch, D. A. Gorgone, M. A. Lifton, K. R. Beaudry, K. Manson, et al. Dysfunction of Simian Immunodeficiency Virus/Simian Human Immunodeficiency Virus-Induced IL-2 Expression by Central Memory CD4+ T Lymphocytes J. Immunol., April 15, 2005; 174(8): 4753 - 4760. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Boritz, B. E. Palmer, and C. C. Wilson Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD4+ T Cells That Proliferate In Vitro Detected in Samples from Most Viremic Subjects and Inversely Associated with Plasma HIV-1 Levels J. Virol., November 15, 2004; 78(22): 12638 - 12646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kolber Impact of Immune Plasticity on Development of Cellular Memory Responses to Human Immunodeficiency Virus Type 1 Clin. Vaccine Immunol., November 1, 2004; 11(6): 1002 - 1007. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |